Derasin, Juanita P.

HRN: 13-06-62  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/08/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/08/2025
01/15/2025
IV
300mg
Every 8hours
Skin Infection
Waiting Final Action 
01/09/2025
MUPIROCIN 2%, 15G (TUBE)
01/09/2025
01/16/2025
TOPICAL
As Needed
BID
Bacterial Skin Infection
Waiting Final Action 
01/10/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/10/2025
01/15/2025
IV
600mg
Q6
DM Dermopathy
Waiting Final Action 
01/10/2025
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
01/10/2025
01/16/2025
TOPICAL
1%
OD
DM Dermopathy
Waiting Final Action 
01/15/2025
CEFAZOLIN 1GM (VIAL)
01/15/2025
01/22/2025
IV
1gm
Q6
Skin Infection
Waiting Final Action 
01/17/2025
MUPIROCIN 2%, 15G (TUBE)
01/17/2025
01/24/2025
TOPICAL
Apply To Affected Area
BID
Bacterial Skin Infection
Waiting Final Action 
01/18/2025
CLINDAMYCIN 300MG (CAP)
01/18/2025
01/25/2025
ORAL
300mg
TID
Infected Wound
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: